StockNews.com Upgrades Applied DNA Sciences (NASDAQ:APDN) to “Sell”

Applied DNA Sciences (NASDAQ:APDN) was upgraded by equities researchers at StockNews.com to a “sell” rating in a note issued to investors on Tuesday.

Separately, HC Wainwright cut their price target on shares of Applied DNA Sciences from $7.00 to $1.50 and set a “buy” rating for the company in a research report on Monday, June 10th.

Applied DNA Sciences Stock Performance

NASDAQ:APDN traded up $0.04 during mid-day trading on Tuesday, reaching $1.37. The stock had a trading volume of 1,704,004 shares, compared to its average volume of 3,745,752. The stock has a market capitalization of $1.35 million, a P/E ratio of -0.08 and a beta of 0.37. The firm has a 50 day moving average price of $0.99 and a two-hundred day moving average price of $3.26. Applied DNA Sciences has a one year low of $0.31 and a one year high of $28.20.

Applied DNA Sciences (NASDAQ:APDN) last posted its quarterly earnings results on Thursday, August 8th. The technology company reported $0.47 EPS for the quarter, topping the consensus estimate of ($0.64) by $1.11. Applied DNA Sciences had a negative net margin of 214.42% and a negative return on equity of 138.41%. The firm had revenue of $0.80 million for the quarter, compared to the consensus estimate of $0.95 million. During the same period last year, the firm posted ($4.80) earnings per share. Research analysts forecast that Applied DNA Sciences will post -1.8 earnings per share for the current year.

Hedge Funds Weigh In On Applied DNA Sciences

A hedge fund recently raised its stake in Applied DNA Sciences stock. AMH Equity Ltd lifted its position in Applied DNA Sciences, Inc. (NASDAQ:APDN) by 46.1% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 540,385 shares of the technology company’s stock after purchasing an additional 170,385 shares during the period. AMH Equity Ltd owned about 63.57% of Applied DNA Sciences worth $222,000 as of its most recent SEC filing. 22.22% of the stock is owned by institutional investors.

About Applied DNA Sciences

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.